Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med

Department of Neuroimmunology, Max Planck Institute of Neurobiology, D-82152 Martinsried, Germany.
Journal of Experimental Medicine (Impact Factor: 13.91). 07/2009; 206(6):1303-16. DOI: 10.1084/jem.20090299
Source: PubMed

ABSTRACT We describe new T cell receptor (TCR) transgenic mice (relapsing-remitting [RR] mice) carrying a TCR specific for myelin oligodendrocyte glycoprotein (MOG) peptide 92-106 in the context of I-A(s). Backcrossed to the SJL/J background, most RR mice spontaneously develop RR experimental autoimmune encephalomyelitis (EAE) with episodes often altering between different central nervous system tissues like the cerebellum, optic nerve, and spinal cord. Development of spontaneous EAE depends on the presence of an intact B cell compartment and on the expression of MOG autoantigen. There is no spontaneous EAE development in B cell-depleted mice or in transgenic mice lacking MOG. Transgenic T cells seem to expand MOG autoreactive B cells from the endogenous repertoire. The expanded autoreactive B cells produce autoantibodies binding to a conformational epitope on the native MOG protein while ignoring the T cell target peptide. The secreted autoantibodies are pathogenic, enhancing demyelinating EAE episodes. RR mice constitute the first spontaneous animal model for the most common form of multiple sclerosis (MS), RR MS.

Download full-text


Available from: Helena Sofia Domingues, Feb 11, 2015
  • Source
    • "Lesion development in presymptomatic sRR-EAE In the sRR-EAE mice (TCR1640 transgenic) the disease develops spontaneously in the absence of immune boosters like the complete Freund's adjuvant and pertussin toxin. In addition, this mouse model closely recapitulates various features of MS, such as the relapsing– remitting pattern in females, the progressive course in males and the brain disease (Pollinger et al., 2009) as opposed to the spinal cord involvement seen in active EAE models. As these mice develop symptoms around day 65, we determined the kinetics of BBB changes during asymptomatic lesion development (days 30 to 55). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Early changes in the normal appearing white matter of multiple sclerosis (MS) patients precede the appearance of gadolinium-enhancing lesions. Although these findings suggest blood-brain barrier (BBB) breakdown as an important feature in MS pathogenesis, limited information is available on the BBB alterations during lesion genesis. Here, we perform a longitudinal characterization of the vascular, neuropathological and immunological changes before lesion formation in mice developing spontaneous relapsing-remitting experimental autoimmune encephalomyelitis (sRR-EAE). We found a significant upregulation of Th1 and Th17 cytokines in the periphery of sRR-EAE mice before any evident neuropathology. In the CNS, BBB and astroglial activations were the first pathological changes occurring after 45days of age and were followed by immune cell infiltration by day 50. These pathological alterations subsequently led to perivascular demyelination and disease onset. In MS, (p)reactive lesions mirrored the changes seen in early sRR-EAE by displaying considerable BBB disruption, perivascular astrogliosis, redistribution of junctional proteins and increased expression of endothelial cell adhesion molecules. Our findings suggest that BBB breach occurs before significant immune cell infiltration and demyelination. In addition, peripheral immune activation during sRR-EAE precedes CNS pathology, suggesting that outside in signaling mechanisms play a role in the development of neuroinflammatory lesions. Copyright © 2014 Elsevier Inc. All rights reserved.
    Neurobiology of Disease 11/2014; 74C:14-24. DOI:10.1016/j.nbd.2014.09.016 · 5.20 Impact Factor
  • Source
    • " al . , 2008 ) suggesting that astrocytes are activated in the very early stages of EAE and in the absence of clinical signs of the disease . In this regard , we have analyzed the state of astrocyte activation in a spontaneous relapsing remitting EAE ( sRR - EAE ) model that closely resembles MS . These animals develop EAE symptoms around day 60 ( Pollinger et al . , 2009 ) and analysis of pre - symptomatic mice showed that at day 35 perivascular astro - cytes show a reactive phenotype as GFAP expression is higher than in wild type littermates and in the absence of immune cell infiltration . The level of astrogliosis increases by day 45 and is associated with low levels of macrophage and T cell infiltrat"
    [Show abstract] [Hide abstract]
    ABSTRACT: The Blood Brain Barrier (BBB) is a specialized vascular structure tightly regulating central nervous system (CNS) homeostasis. Endothelial cells are the central component of the BBB and control of their barrier phenotype resides on astrocytes and pericytes. Interactions between these cells and the endothelium promote and maintain many of the physiological and metabolic characteristics that are unique to the BBB. In this review we describe recent findings related to the involvement of astroglial cells, including radial glial cells, in the induction of barrier properties during embryogenesis and adulthood. In addition, we describe changes that occur in astrocytes and endothelial cells during injury and inflammation with a particular emphasis on alterations of the BBB phenotype. GLIA 2013.
    Glia 12/2013; 61(12). DOI:10.1002/glia.22575 · 6.03 Impact Factor
  • Source
    • "After an initial period of experimentation with active sensitization, murine models of chronic demyelination progressed to adoptive-transfer technologies, whereby CNS antigen-specific bulk-isolated lymphocytes, T cell lines or T cell clones were administered intravenously into naïve recipients (Brown and McFarlin, 1981). Recently, transgenic murine models have been developed in which disease arises spontaneously, mostly through insertion of myelin-specific human T cell receptors and human histocompatibility complex antigens (Ellmerich et al., 2005; Pöllinger et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is an inflammatory autoimmune demyelinating disease affecting the Central Nervous System, in which Th1 and Th17 cells appear to recognize and react against certain myelin sheath components. Epidemiological evidence has accumulated indicating steady increase in autoimmune disease incidence in developed countries. Reduced infectious disease prevalence in particular has been proposed as the cause. In agreement with this hypothesis, we recently demonstrated significantly better clinical and radiological outcome in helminth-infected MS patients, compared to uninfected ones. Parasite-driven protection was associated with regulatory T cell induction and anti-inflammatory cytokine secretion, including increased TGF-β and IL-10 levels. Interestingly, surface expression of TLR2, on both B cells and dendritic cells (DC) was significantly higher in infected MS patients. Moreover, stimulation of myelin-specific T cell lines with a TLR2 agonist induced inhibition of T cell proliferation, suppression of IFN-γ, IL-12 and IL-17 secretion, as well as increase in IL-10 production, suggesting the functional responses observed correlate with TLR2 expression patterns. Furthermore, parasite antigens were able to induce TLR2 expression on both B cells and DCs. All functional effects mediated by TLR2 were abrogated when MyD88 gene expression was silenced; indicating helminth–mediated signaling induced changes in cytokine secretion in a MyD88-dependent manner. In addition, helminth antigens significantly enhanced co-stimulatory molecule expression, effects not mediated by MyD88. Parasite antigens acting on MyD88 induced significant ERK kinase phosphorylation in DC. Addition of the ERK inhibitor U0126 was associated with dose-dependent IL-10 inhibition and reciprocal enhancement in IL-12, both correlating with ERK inhibition. Finally, cytokine effects and changes observed in co-stimulatory DC molecules after helminth antigen exposure were lost when TLR2 was sile
    Frontiers in Cellular and Infection Microbiology 08/2012; 2:112. DOI:10.3389/fcimb.2012.00112 · 2.62 Impact Factor
Show more